Oslo Børs: CSAM Health admitted to trading
Oslo, 9 October 2020 – The eHealth company CSAM Health has today been admitted to trading on Merkur Market (ticker code: CSAM-ME).
CSAM Health recently raised NOK 825 million through a private placement, consisting of NOK 325 million in new shares and NOK 500 million from existing shareholders. The placement attracted strong interest from Nordic and international investors and was significantly oversubscribed, reported CSAM.
“We are proud and happy for the great interest that CSAM has experienced from both Nordic and international quality investors”, says Sverre Flatby, CEO of CSAM.
“Today represents a milestone in CSAM’s history – through this IPO we significantly broaden the shareholder base and thereby gain access to capital to continue our strong expansion”, continues Einar Bonnevie, CFO of CSAM.
CSAM has also closed a NOK 300 million bond issue, that the company aims to list on Nordic ABM.
About CSAM Health Group
CSAM is the leading provider of niche eHealth solutions in the Nordics. The company’s leading product portfolio includes innovative niche solutions in connected healthcare, medical imaging, women and children’s health, emergency and acute care, medication management, and laboratory information management systems, that enable healthcare providers to access relevant clinical information at the point of care. CSAM is headquartered in Oslo, and has operations in Norway, Sweden, Finland, Denmark, and the UK, as well as a wholly owned software engineering subsidiary in the Philippines. www.csamhealth.